
	Three months ended June 30, 2025	Three months ended June 30, 2024	Six months ended June 30, 2025	Six months ended June 30, 2024
Basic income per share	0.15	0.13	0.08	0.18
Diluted income per share	0.14	0.12	0.08	0.18

Issued ordinary shares at the end of the period	244,400,000	264,080,391	244,400,000	264,080,391

Net income - basic	35.1	31.7	18.2	46.1
Convertible bond interest using the if converted method	3.0	3.0	—	6.0
Net income - diluted	38.1	34.7	18.2	52.1

Weighted average numbers of shares outstanding for the period, basic	238,907,129	251,189,331	241,134,285	251,953,928
Dilutive effect of share options and RSU (1)	34,970,601	37,247,299	1,228,215	37,395,409
Weighted average numbers of shares outstanding for the period, diluted	273,877,730	288,436,630	242,362,500	289,349,337

(1) For the three months ended June 30, 2025, 3,931,663 share options, 136,610 restricted stock units using the treasury stock method and 34,507,611 shares issuable upon exercise of our Convertible Bonds with a conversion price of $6.9376 per share have been included as they are dilutive. For the six months ended June 30, 2025, 3,931,663 share options using the treasury stock method have been included as they are

dilutive. For the three and six months ended June 30, 2024, 8,118,362 share options and 862,780 restricted stock units using the treasury stock method and 33,554,319 shares issuable upon exercise of our Convertible Bonds with a conversion price of $7.1347 per share, have been included as they are dilutive.

The weighted average number of shares outstanding includes 2,208,734 and 12,081,900 shares as of June 30, 2025 and June 30, 2024 shares, respectively, which have been issued as part of a share lending arrangement relating to the Company's issuance of $250.0 million Convertible Bonds in 2023 (see Note 21 - Common Shares).

The following potential share issuances effects of Convertible Bonds, share options, RSUs and performance units have been excluded from the calculation of diluted EPS for each of the periods presented because the effects were anti-dilutive.


	Three months ended June 30, 2025	Three months ended June 30, 2024	Six months ended June 30, 2025	Six months ended June 30, 2024
Convertible bonds	—	—	34,507,611	—
Share options	8,689,997	2,100,000	8,689,997	2,100,000
Performance stock units	750,000	750,000	750,000	750,000
Restricted share units	750,000	—	886,610	—

For the three months ended June 30, 2025, the impact of 8,689,997 share options, 750,000 performance share units, and 750,000 restrictive share units have been excluded from the calculation of EPS as the exercise price was higher than the average share price, and therefore have been excluded from the calculation. For the six months ended June 30, 2025, the impact of 8,689,997 share options, 750,000 performance share units, and 886,610 restricted share units have been excluded from the calculation of EPS as the exercise price was higher than the average share price, and therefore have been excluded from the calculation. In addition, 34,507,611 shares issuable upon exercise of our Convertible Bonds with a conversion price of $6.9376 per share, have been excluded as they are anti-dilutive.